 |
 |
 |
|
 |
articles < press << main |
 |
 |
|
|
|
|
|
|
|
| date | | | | title / topic / summary | sort by topic |
|---|
|
| 06/19/2003 | | | | Nymox Management Projection of Up to Four New INDs in the Next 12 Months
topic: Financial
June 19, 2003: Nymox Pharmaceutical Corporation announced today that the Company's management anticipates filing as many as 4 Investigational New Drug applications (INDs) for new products in the next 12 months. |
| 06/17/2003 | | | | Nymox Pharmaceutical Corporation Recommended in Two Independent Analyst Reports
topic: Financial
June 17, 2003: Two recent independent analyst reports have recommended Nymox Pharmaceutical Corporation (NASDAQ: NYMX). The "buy" recommendation from Kareg Corporation was written by Sheldon S. Traube, Director of Research on June 16, 2003. The "buy" recommendation from Dutton and Company was written by Sherry Grisewood, CFA on May 15, 2003. |
| 06/16/2003 | | | | Nymox Rated "Buy" By Kareg Corporation Analyst
topic: Financial
June 16, 2003: In a new independent investment research report by Kareg Corporation, Nymox Pharmaceutical Corporation shares are given a "buy" recommendation. |
| 06/11/2003 | | | | Nymox Innovative Alzheimer Drug Programs Report Progress
topic: R&D: Alzheimer's Disease Treatments
June 11, 2003: Nymox Pharmaceutical Corporation reported today that its key Alzheimer's disease (AD) drug development programs have resulted in several leading candidates for new treatments in AD. The Company has a broad-based set of programs in AD, which feature innovation and strong global patent positions. |
| 06/10/2003 | | | | Nymox Reports Progress in Oncology Collaboration With Brown University Medical Researchers
topic: R&D: Cancer Treatments
June 10, 2003: Nymox Pharmaceutical Corporation announced progress in its collaboration on oncology product developments with Dr. Jack Wands and colleagues at Brown University. Nymox reported today that the sponsored research and development agreement has moved ahead significantly. |
| 06/09/2003 | | | | Nymox NicAlert™ Product Used Successfully in European Broadcast TV Smoking Cessation Program
topic: Tobacco Exposure Tests
June 9, 2003) Nymox Pharmaceutical Corporation and health4u AG (Allschwil, Switzerland) announced today that Nymox's NicAlert™ product was successfully used in a smoking cessation program organized by the popular weekly Swiss TV program on health, "Gesundheitssprechstunde," created and moderated by Dr. S. Stutz. |
| 06/09/2003 | | | | Nymox NicAlert™ Product Used to Help High School Students Quit Smoking
topic: Tobacco Exposure Tests
June 9, 2003: Nymox's NicAlert™ product was successfully used in 2003 as part of an extended anti-smoking program for teenage students in Switzerland. |
| 06/06/2003 | | | | Nymox Reports Positive Alzheimer Drug Candidate Research
topic: R&D: Alzheimer's Disease Treatments
June 6, 2003: Nymox Pharmaceutical Corporation announced today that its Alzheimer's disease (AD) drug research has led to significant new milestones. The Company reported that its underlying activities in drug discovery, drug distribution, toxicology, and chemical analysis have passed important new milestones. |
| 06/05/2003 | | | | Task Force Report Highlights Need for Accurate Diagnosis of Alzheimer's Disease
topic: AlzheimAlert™ & Diagnosis of Alzheimer's Disease
June 5, 2003: The need to improve the accuracy of the diagnosis of Alzheimer's disease was highlighted by a newly released report from the U.S. Preventive Services Task Force. The report, Screening for Dementia: Recommendations and Rationale, reviewed the detection of dementia in older adults. According to the Report, "patients who had not received a dementia diagnosis accounted for 50% to 66% of all cases of dementia in the primary care samples studied." The Report concluded "the concept of detecting dementia at an early stage to allow interventions is a good one. Screening for dementia is worth pursuing with further research." |
| 06/04/2003 | | | | Smoking During Pregnancy Affects Newborn Behavior According to New Study
topic: Tobacco Exposure Tests
June 4, 2003: A new published study has found that smoking during pregnancy is associated with newborns who are more excitable, less consolable and more rigid. The study also found that the more the nicotine exposure as measured by cotinine levels in the pregnant mothers, the more there were signs of stress seen in the newborns. |
|